Diffblue, an artificial intelligence company from Oxford, has successfully generated $22m in a funding round, a year after it split off from the University of Oxford. The firm is now working on developing its own AI for medical diagnosis and treatment.
Diffblue, an artificial intelligence company from Oxford, has successfully generated $22m in a funding round, a year after it split off from the University of Oxford. The Series A round, led by Goldman Sachs Principal Strategic Investments, will provide funding for the launch of three products: a testing product that auto-generates readable tests for a codebase, a security product that detects security weaknesses and runs actual exploits, and a refactoring product that rewrites bad or outdated code.